Study note

Hyperbilirubinemia treatment charts for neonates of at least 35 weeks

THE CONTEXT
The supplied passage describes how to select and interpret the AAP hyperbilirubinemia treatment charts.

Scope and chart selection

•
The American Academy of Pediatrics (AAP) 2022 guidance covers hyperbilirubinemia management in neonates of 35 weeks' gestation or more.
•
Charts are provided for phototherapy and exchange transfusion, with separate charts for neonates with and without neurotoxicity risk factors.

Reading the charts

•
The X-axis shows postnatal age in hours, and the Y-axis shows total serum bilirubin.
•
Each plotted line represents a different gestational age.
Explore this chapter
NEETx
Learn. Practise. Remember.